|
IT951631B
(it)
|
1971-03-18 |
1973-07-10 |
Richardson Merrell Spa |
Composti utili per la separazione di isomeri ottici geometrici e strutturali e relativo procedimen to di sintesi
|
|
GB2160202B
(en)
|
1984-06-12 |
1987-12-02 |
Nat Res Dev |
Preparation of tamoxifen
|
|
GB8604528D0
(en)
|
1986-02-24 |
1986-04-03 |
Ici Plc |
Therapeutic agents
|
|
US6881548B2
(en)
|
1997-05-23 |
2005-04-19 |
A&G Pharmaceutical, Inc. |
Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy
|
|
US6638727B1
(en)
|
1999-01-26 |
2003-10-28 |
Cytyc Health Corporation |
Methods for identifying treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer
|
|
US6398765B1
(en)
|
1999-03-01 |
2002-06-04 |
Pro Duct Health, Inc. |
Apparatus, methods and kits for simultaneous delivery of a substance to multiple breast milk ducts
|
|
US6245352B1
(en)
|
1999-04-27 |
2001-06-12 |
Eli Lilly And Company |
Pharmaceutical formulation
|
|
WO2001001962A1
(en)
|
1999-07-05 |
2001-01-11 |
Idea Ag. |
A method for the improvement of transport across adaptable semi-permeable barriers
|
|
GB0000313D0
(en)
|
2000-01-10 |
2000-03-01 |
Astrazeneca Uk Ltd |
Formulation
|
|
GB0008172D0
(en)
|
2000-04-05 |
2000-05-24 |
Astrazeneca Ab |
Therapy
|
|
US6416981B1
(en)
|
2000-05-23 |
2002-07-09 |
Nec Partnership |
Production of gluconate salts
|
|
CN1298317C
(zh)
|
2001-11-07 |
2007-02-07 |
斯索恩有限公司 |
坦洛新片剂
|
|
WO2004054558A2
(en)
|
2002-12-18 |
2004-07-01 |
Laboratoires Besins International |
Reduction of breast density with 4-hydroxy tamoxifen
|
|
MXPA05006526A
(es)
|
2002-12-18 |
2006-02-17 |
Besins Int Lab |
Tratamiento de mastalgia con 4-hidroxi tamoxifen.
|
|
ES2456957T3
(es)
|
2003-04-01 |
2014-04-24 |
Besins Healthcare Luxembourg Sarl |
Tratamiento de cáncer de seno con 4-hidroxitamoxifen
|
|
EP1663142A2
(en)
|
2003-06-23 |
2006-06-07 |
MacroChem Corporation |
Compositons and methods for topical administration
|
|
US7531578B2
(en)
|
2003-09-18 |
2009-05-12 |
City Of Hope |
Compounds and methods for treating breast cancer and other diseases
|
|
US7968532B2
(en)
|
2003-12-15 |
2011-06-28 |
Besins Healthcare Luxembourg |
Treatment of gynecomastia with 4-hydroxy tamoxifen
|
|
EP1709062B9
(en)
|
2004-01-16 |
2013-02-13 |
Cedarburg Pharmaceuticals, Inc. |
Exemestane and its intermediates and methods of making the same
|
|
WO2005089511A2
(en)
|
2004-03-19 |
2005-09-29 |
Transform Pharmaceuticals, Inc. |
Novel pharmaceutical forms, and methods of making and using the same
|
|
US7507769B2
(en)
|
2004-03-22 |
2009-03-24 |
Laboratoires Besins International |
Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
|
|
EP1865992A2
(en)
|
2005-03-31 |
2007-12-19 |
Mytogen Inc. |
Treatment for heart disease
|
|
US20060280795A1
(en)
|
2005-06-08 |
2006-12-14 |
Dexcel Pharma Technologies, Ltd. |
Specific time-delayed burst profile delivery system
|
|
KR100917698B1
(ko)
|
2005-07-06 |
2009-09-21 |
시코르, 인크. |
레트로졸의 제조를 위한 개선된 방법
|
|
CN102225046A
(zh)
|
2005-08-05 |
2011-10-26 |
努沃研究公司 |
透皮释药剂型
|
|
US8034824B2
(en)
|
2005-10-12 |
2011-10-11 |
Kowa Co., Ltd. |
Iontophoretic preparation for treatment of breast cancer and/or mastitis
|
|
US20090208944A1
(en)
|
2005-12-09 |
2009-08-20 |
Goetz Matthew P |
Assessing outcomes for breast cancer patients treated with tamoxifen
|
|
ES2540561T3
(es)
|
2005-12-20 |
2015-07-10 |
Incyte Corporation |
N-hidroxiamidinoheterociclos como moduladores de indolamina 2,3-dioxigenasa
|
|
US9308181B2
(en)
|
2006-03-06 |
2016-04-12 |
Nuvo Research Inc. |
Topical formulations, systems and methods
|
|
WO2007141799A1
(en)
|
2006-06-05 |
2007-12-13 |
Cadila Healthcare Limited |
A process for preparing pure anastrozole
|
|
CL2007002851A1
(es)
|
2006-10-05 |
2008-01-18 |
M S Panacea Biotec Ltd |
Composicion inyectable que comprende micro o nano -particulas biodegradables que incluyen un agente activo, un polimero biodegardable, un agente para intensificar la viscosidad y excipiente farmaceuticamente aceptables; y procedimientos de preparacion
|
|
US20090291134A1
(en)
|
2006-11-21 |
2009-11-26 |
Jina Pharmaceuticals, Inc. |
Endoxifen methods and compositions in the treatment of psychiatric and neurodegenerative diseases
|
|
US20120164075A1
(en)
|
2006-11-21 |
2012-06-28 |
Jina Pharmaceuticals, Inc. |
Endoxifen methods and compositions in the treatment of mammalian diseases
|
|
ES2665917T3
(es)
|
2006-11-21 |
2018-04-30 |
Jina Pharmaceuticals Inc. |
Endoxifeno para su uso en el tratamiento del cáncer
|
|
EP2097085A4
(en)
|
2006-11-27 |
2010-02-10 |
Ariad Pharma Inc |
THERAPEUTIC MATERIALS AND METHOD
|
|
WO2008067991A2
(en)
|
2006-12-08 |
2008-06-12 |
Antares Pharma Ipl Ag |
Skin-friendly drug complexes for transdermal administration
|
|
AU2008229604B2
(en)
|
2007-03-20 |
2013-05-30 |
Scf Pharma Inc. |
Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
|
|
US8454945B2
(en)
|
2007-03-22 |
2013-06-04 |
Berg Pharma Llc |
Topical formulations having enhanced bioavailability
|
|
US20090068190A1
(en)
|
2007-08-29 |
2009-03-12 |
Drugtech Corporation |
Anti-proliferative combinations
|
|
AR068409A1
(es)
|
2007-09-14 |
2009-11-18 |
Drugtech Corp |
Composiciones farmaceuticas, transdermicas sin alcohol
|
|
WO2009069140A1
(en)
|
2007-11-28 |
2009-06-04 |
Dabur Pharma Limited |
An improved process for preparation of letrozole and its intermediates
|
|
WO2009120999A2
(en)
|
2008-03-28 |
2009-10-01 |
Olema Pharmaceuticals, Inc. |
Use of an endoxifen prodrug for treatment of breast cancer
|
|
WO2009129352A2
(en)
|
2008-04-15 |
2009-10-22 |
Windy Hill Medical |
Device and method for accessing and treating ducts of mammary glands
|
|
US8063249B1
(en)
|
2008-04-25 |
2011-11-22 |
Olema Pharmaceuticals, Inc. |
Substituted triphenyl butenes
|
|
RS57132B1
(sr)
|
2008-07-08 |
2018-07-31 |
Incyte Holdings Corp |
1,2,5-oksadiazoli kao inhibitori indolamin 2,3-dioksigenaze
|
|
CN102159257B
(zh)
|
2008-07-17 |
2015-11-25 |
米歇尔技术公司 |
药物递送医疗设备
|
|
EP2350111A1
(en)
|
2008-10-15 |
2011-08-03 |
Synthon B.V. |
Processes and intermediates for the production of fulvestrant
|
|
US20100098659A1
(en)
|
2008-10-22 |
2010-04-22 |
Revalesio Corporation |
Compositions and methods for treating matrix metalloproteinase 9 (mmp9)-mediated conditions
|
|
DK3202420T3
(da)
|
2008-12-11 |
2020-04-06 |
Besins Healthcare Lu Sarl |
Transdermale farmaceutiske sammensætninger omfattende en serm
|
|
CN101891635B
(zh)
*
|
2009-05-21 |
2014-06-04 |
扬子江药业集团有限公司 |
枸橼酸他莫昔芬的晶型及晶型a的制备方法
|
|
US9132084B2
(en)
*
|
2009-05-27 |
2015-09-15 |
Neothetics, Inc. |
Methods for administration and formulations for the treatment of regional adipose tissue
|
|
US20100317635A1
(en)
|
2009-06-16 |
2010-12-16 |
Endorecherche, Inc. |
Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
|
|
US20120149761A1
(en)
|
2009-08-27 |
2012-06-14 |
Atossa Genetics, Inc. |
Nucleic acid molecules and uses thereof
|
|
US8637569B2
(en)
|
2009-10-22 |
2014-01-28 |
Api Genesis, Llc |
Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds
|
|
WO2011072244A1
(en)
|
2009-12-10 |
2011-06-16 |
Mount Sinai School Of Medicine Of New York University |
Method of treatment of breast cancer with tamoxifen
|
|
EP2425833A1
(de)
|
2010-09-03 |
2012-03-07 |
Fresenius Kabi Deutschland GmbH |
Die intravenöse Applikation von Fischöl/DHA +EPA vor bzw. mit Beginn der Chemotherapie
|
|
KR101308258B1
(ko)
|
2010-10-15 |
2013-09-13 |
씨제이제일제당 (주) |
엔독시펜의 신규한 제조 방법
|
|
EP2468264A1
(en)
|
2010-12-27 |
2012-06-27 |
Laboratorios Liconsa, S.A. |
Oral pharmaceutical tablet for controled release of mesalazine and process for obtaining it
|
|
WO2012125445A2
(en)
|
2011-03-11 |
2012-09-20 |
President And Fellows Of Harvard College |
Small molecule-dependent inteins and uses thereof
|
|
EP2508174A1
(en)
|
2011-04-06 |
2012-10-10 |
Ljiljana Sovic Brkicic |
Pharmaceutical composition
|
|
WO2012162492A1
(en)
|
2011-05-24 |
2012-11-29 |
Teva Pharmaceutical Industries Ltd. |
Compressed core comprising organic acids for a pharmaceutical composition
|
|
US9090640B2
(en)
|
2011-09-02 |
2015-07-28 |
Ulrich Bierbach |
Targeted delivery and prodrug designs for platinum-acridine anti-cancer compounds and methods thereof
|
|
FR2980972B1
(fr)
|
2011-10-05 |
2014-02-28 |
Commissariat Energie Atomique |
Formulations pour le diagnostic et le traitement de cancers hormonodependants et de cancers des organes de synthese d'hormones steroidiennes.
|
|
EP2822955B1
(en)
|
2012-03-05 |
2017-07-26 |
Xavier University |
Boron-based 4-hydroxytamoxifen and endoxifen prodrugs as treatment for breast cancer
|
|
WO2014012117A1
(en)
|
2012-07-13 |
2014-01-16 |
South Dakota State University |
Compositions and methods for localized drug delivery through mammary papillae
|
|
EP2909163A1
(en)
|
2012-10-19 |
2015-08-26 |
Fermion Oy |
A process for the preparation of ospemifene
|
|
KR20150087400A
(ko)
|
2012-11-20 |
2015-07-29 |
버텍스 파마슈티칼스 인코포레이티드 |
인돌아민 2,3-디옥시게나제의 억제제로서 유용한 화합물
|
|
MX378463B
(es)
|
2013-02-26 |
2025-03-10 |
Memorial Sloan Kettering Cancer Center |
Composiciones y usos de las mismas para inmunoterapia.
|
|
IN2013MU00646A
(OSRAM)
|
2013-03-04 |
2015-06-26 |
Intas Pharmaceuticals Ltd |
|
|
AU2014251038A1
(en)
|
2013-04-08 |
2015-11-26 |
Dennis M. Brown |
Therapeutic benefit of suboptimally administered chemical compounds
|
|
TW201536278A
(zh)
*
|
2013-05-31 |
2015-10-01 |
Del Mar Pharmaceuticals |
雙脫水半乳糖醇及其類似物與衍生物用於治療復發性惡性神經膠瘤或進行性繼發腦瘤之用途
|
|
AU2014334531B2
(en)
|
2013-10-18 |
2019-05-16 |
The Regents Of The University Of Michigan |
Systems and methods for determining a treatment course of action
|
|
HUP1300646A2
(en)
|
2013-11-12 |
2015-05-28 |
Druggability Technologies Ip Holdco Jersey Ltd |
Complexes of fulvestrant and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them
|
|
WO2015106094A1
(en)
|
2014-01-10 |
2015-07-16 |
Atossa Genetics Inc. |
Transpapillary methods and compositions for diagnosing and treating breast conditions
|
|
US9744177B2
(en)
|
2014-03-10 |
2017-08-29 |
Endorecherche, Inc. |
Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM
|
|
US9914696B2
(en)
|
2014-03-11 |
2018-03-13 |
Repros Therapeutics Inc. |
Clomiphene synthesis using a single solvent
|
|
EP3152579A4
(en)
|
2014-06-04 |
2018-01-17 |
Atossa Genetics Inc. |
Molecular mammography
|
|
CN104230723B
(zh)
|
2014-08-21 |
2016-08-24 |
凯莱英医药集团（天津）股份有限公司 |
托瑞米芬的合成方法
|
|
JP2018514511A
(ja)
|
2015-04-14 |
2018-06-07 |
アトッサ ジェネティックス インク． |
乳房障害とエストロゲン関連障害の処置のための組成物と方法
|
|
WO2016187122A1
(en)
|
2015-05-15 |
2016-11-24 |
University Of Iowa Research Foundation |
Methods for treating tumors in situ including intratumor injection of cytotoxic particles and immune checkpoint blockade therapy
|
|
EP3322406A4
(en)
|
2015-07-14 |
2019-06-12 |
Atossa Genetics Inc. |
TRANSPAPILLARY METHOD AND COMPOSITION FOR THE TREATMENT OF BREAST DISEASES
|
|
EP3365322B1
(en)
*
|
2015-10-22 |
2021-05-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Process for preparing (z)-endoxifen of high purity
|
|
DE102015222031A1
(de)
*
|
2015-11-10 |
2017-05-11 |
Robert Bosch Gesellschaft Für Medizinische Forschung Mbh |
Synthese von (Z)-Endoxifenhydrochlorid
|
|
US20170304232A1
(en)
|
2016-04-20 |
2017-10-26 |
Northwestern University |
Endoxifen For Local Transdermal Therapy To The Breast
|
|
IL272924B2
(en)
|
2017-09-11 |
2024-01-01 |
Atossa Therapeutics Inc |
Methods for making and using endoxifen
|
|
KR20200051690A
(ko)
|
2017-09-11 |
2020-05-13 |
아토사 테라퓨틱스, 인크. |
국소 조성물
|
|
EP3681478B1
(en)
|
2017-09-11 |
2025-09-10 |
Atossa Therapeutics, Inc. |
Topical compositions and methods for treatment
|